Personality traits as risk factors for treatment-resistant depression.

par Michio Takahashi, Yukihiko Shirayama, Katsumasa Muneoka, Masatoshi Suzuki, Koichi Sato, Kenji Hashimoto
Publié 2013

Low openness on the revised NEO personality inventory as a risk factor for treatment-resistant depression.

par Michio Takahashi, Yukihiko Shirayama, Katsumasa Muneoka, Masatoshi Suzuki, Koichi Sato, Kenji Hashimoto
Publié 2013

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study.

par Daisuke Matsuzawa, Takayuki Obata, Yukihiko Shirayama, Hiroi Nonaka, Yoko Kanazawa, Eiji Yoshitome, Junichi Takanashi, Tsuyoshi Matsuda, Eiji Shimizu, Hiroo Ikehira, Masaomi Iyo, Kenji Hashimoto
Publié 2008

Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype

par Ji-chun Zhang, Wei Yao, Youge Qu, Mayumi Nakamura, Chao Dong, Chun Yang, Qian Ren, Min Ma, Mei Han, Yukihiko Shirayama, Akiko Hayashi-Takagi, Kenji Hashimoto
Publié 2017

Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses

par Takehiko Yamanashi, Masaaki Iwata, Naho Kamiya, Kyohei Tsunetomi, Naofumi Kajitani, Nodoka Wada, Takahiro Iitsuka, Takahira Yamauchi, Akihiko Miura, Shenghong Pu, Yukihiko Shirayama, Ken Watanabe, Ronald S. Duman, Koichi Kaneko
Publié 2017

Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model

par Takehiko Yamanashi, Masaaki Iwata, Midori Shibushita, Kyohei Tsunetomi, Mayu Nagata, Naofumi Kajitani, Akihiko Miura, Ryoichi Matsuo, Tsuyoshi Nishiguchi, Takahiro A. Kato, Daiki Setoyama, Yukihiko Shirayama, Ken Watanabe, Gen Shinozaki, Koichi Kaneko
Publié 2020